Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home » EU reaches deal on tackling shortages of essential medicines

    EU reaches deal on tackling shortages of essential medicines

    eub2eub212 May 2026Updated:13 May 2026 Health
    — Filed under: EU News
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The EU Parliament and Council have reached a provisional deal on a new regulation that seeks to strengthen the EU’s resilience in addressing ongoing challenges to security of supply of critical medicines in Europe.

    The aim of the critical medicines act (CMA) is to tackle shortages of key medicines such as antibiotics, insulin and painkillers by improving security of supply and availability of critical medicines, and medicines of common interest in the EU.

    The new rules seek to diversify supply chains of critical medicines, make it easier for EU countries to join forces to procure critical medicines, and strengthen the manufacturing capacity for critical medicines and their active ingredients within the EU.

    “Patients should not have to worry about whether critical medicines such as antibiotics will be available at their pharmacy or hospital”, said Cyprus’ Health minister Neophytos Charalambides, for the EU presidency: “With today’s agreement, we are taking practical action to reduce our vulnerabilities, diversify supply chains and strengthen Europe’s capacity to produce critical medicines and their ingredients closer to home.”

    Under the agreed Critical Medicines Act:

    • Member States will have to diversify and incentivise resilience in the medicine supply chains during public procurement procedures. For critical medicines, procurers will have to support the diversification and reliability of supply sources. In case of a high dependency on a single or a limited number of third countries, the CMA goes further, foreseeing the obligation for contracting authorities to favour “manufacturing in the EU”.
    • The creation of Strategic Projects to boost, increase or modernise EU manufacturing capacity for critical medicines or their active substances, through easier access to (Member State and Union) funding as well as fast-tracked administrative support. In addition, projects for manufacturing of orphan medicines will also benefit from faster permitting.
    • When Member States require companies to hold contingency stocks, they will have to ensure that this does not negatively affect supply of critical medicines in other countries in the Union. Member States will also have to share up to date information on contingency stocks available for reallocation when a call for solidarity is launched through the Voluntary Solidarity Mechanism.
    • Collaborative procurement will be available for Member States to address availability and access disparities of critical medicines, orphan medicines and other medicines of common interest throughout the EU.
    • Strategic partnerships with international partners will be explored, to broaden the supply chain and reduce dependencies on single or limited numbers of suppliers.

    The political agreement is now subject to formal approval by the European Parliament and the Council.

    Proposal for a Critical Medicines Act

    Questions and answers on the Critical Medicines Act

    Factsheet – EU Actions to address medicines shortages

    Factsheet – Critical Medicines Act

    Add A Comment
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    eub2
    • Website

    eub2 is the default publisher for EUbusiness.

    Related Content

    Running - Image by Th G from Pixabay

    EU sets out vision for sport in Europe

    AIM logo

    Project Manager, International Association of Mutual Benefit Societies, AIM

    ESIP - European Social Insurance Platform logo

    Policy Officer in Healthcare, European Social Insurance Platform, ESIP

    Access VetMed logo

    Public Affairs Advisor, Access VetMed

    Wine bottles - Photo by CHUTTERSNAP on Unsplash

    5 pct of Europeans consumed alcohol daily in 2025

    Health screening - Image © European Union 2026

    Brussels launches EU Screening Week

    LATEST EU NEWS
    Wrapping plastics packaging - Photo by Léster Lau on Pexels

    Rules prohibiting EU exports of plastic waste to non-OECD countries enter into force

    20 November 2026
    UK-EU-Ursula von der Leyen, Andy Burnham, António Costa - Photo © European Union 2026

    Brexit reset underway as UK’s deal with EU offers new opportunities for young people

    20 November 2026
    Oil tanker - Image by Erich Westendarp from Pixabay

    EU to delay methane reporting and monitoring for energy importers

    19 November 2026
    AI - Artificial Intelligence - Image by Gerd Altmann from Pixabay

    EU calls on states to equip citizens for the age of AI

    19 November 2026
    Euro - ECB-Photo by Mika Baumeister on Unsplash

    November currency outlook – Euro currency news

    19 November 2026

    Subscribe to EUbusiness Week

    Get the latest EU news

    CONTACT INFO

    • EUbusiness, 117 High Street, Chesham Buckinghamshire, HP5 1DE, United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Cookie Policy
    • Terms
    • Disclaimer

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2026

    Type above and press Enter to search. Press Esc to cancel.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}
    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?